Hypermutated / microsatellite unstable (MSI) group: These tumors have mutations in the RTK (receptor tyrosine kinase) / RAS / beta-catenin pathway and PIK3CA / PIK3R1-PTEN pathway and frequent MLH1 promoter methylation and reduced MLH1 gene expression.